GDAP1 and neuroblastoma: In the present study, we have shown for the first time that the TGN may also be disrupted in CMT disease or at least in some CMT subtypes caused by mutations within GDAP1. We have revealed this in a series of three independent experiments encompassing neuroblastoma, HeLa and yeast cells.